Pink Cocaine, it isn’t
When I've seen people attempt to explain their motives, they usually blame it on the trust they had in their source -- whoever gave or sold it to them at the time. That trust was misplaced, they complain.
Select Page
by C. Scott McMillin | Apr 15, 2024 | Addictive Substances | 0 |
When I've seen people attempt to explain their motives, they usually blame it on the trust they had in their source -- whoever gave or sold it to them at the time. That trust was misplaced, they complain.
by C. Scott McMillin | Apr 11, 2024 | In the News | 0 |
by C. Scott McMillin | Apr 8, 2024 | In the News | 0 |
by C. Scott McMillin | Dec 4, 2023 | Addictive Substances | 0 |
by C. Scott McMillin | Oct 26, 2023 | In the News | 0 |
by C. Scott McMillin | Oct 2, 2023 | Public Policy | 0 |
by C. Scott McMillin | Sep 28, 2023 | In the News | 0 |
The DEA has committed to a public information campaign around the theme of “one pill can kill”. Although that’s technically true, I don’t know how much impact it will have on the target audience.
Read Moreby C. Scott McMillin | Sep 14, 2023 | Addictive Substances | 0 |
All that free positive publicity has surely been a great help to the emerging psychedelic industry and the elements in the financial community who are rushing to exploit it.
Read Moreby C. Scott McMillin | Sep 7, 2023 | In the News | 0 |
…some patients feel ‘gypped’ if they don’t leave the office with a prescription. And respond with a bad review on the patient satisfaction survey.
Read Moreby C. Scott McMillin | Aug 31, 2023 | Addictive Substances | 0 |
As many as fifty of these NPS designer drugs have been found to date. That sounds like a lot until we realize the potential for hundreds more to appear in future.
Read Moreby C. Scott McMillin | Sep 15, 2022 | In the News | 0 |
A DC lobbyist…filed a suit claiming that John Boehner and an associated law firm had stolen his idea, and the plans for implementing it, without giving him credit (or paying him)
Read Moreby C. Scott McMillin | Sep 5, 2022 | In the News | 0 |
One thing that emerged is that Walgreen’s own pharmacists had made repeated attempts to convince corporate leadership to establish a central database of suspicious purchases, and the customers who made them.
Read Moreby C. Scott McMillin | Aug 29, 2022 | Addictive Substances, Public Policy | 0 |
More impressive results have come from simply increasing taxes on alcoholic beverages. States that have done so have been rewarded, mostly through reductions in the consequences of excessive drinking.
Read Moreby C. Scott McMillin | Jul 25, 2022 | Thinking About Addiction | 0 |
whatever McKinsey was charging for its services, their clients couldn’t have done what they did without McKinsey’s help. Sure, that led to a drug epidemic such as America has never seen, costing some half a million lives to date.
Read Moreby C. Scott McMillin | Jul 21, 2022 | In the News | 0 |
…there were some real doozies, scripts written for amounts way beyond any conceivable patient need.
Read Moreby C. Scott McMillin | Jun 2, 2022 | In the News | 0 |
The Gold Rush atmosphere is because everyone is expecting the arrival of bigger, better-funded, publicly-traded cannabis companies, accompanied by their networks of retail stores.
Read Moreby C. Scott McMillin | May 30, 2022 | Addictive Substances | 0 |
…one past error has been to overemphasize the more glamorous supply side interventions – interdiction and law enforcement – while paying much less attention to the demand side of the bargain.
Read Moreby C. Scott McMillin | May 26, 2022 | In the News | 0 |
By the time the authorities get around to questioning it, you’ll have collected more than enough revenue to pay your legal fees.
Read More